Submissions to the Medicines Classification Committee for the Reclassification of

First Page		Document Content
Date: 2014-05-20 20:50:21 Antipruritics Amines Mepyramine Pyridines Topical Lidocaine Pharmaceutical drug Pharmacy Pseudoephedrine Medicine Pharmacology Chemistry		Submissions to the Medicines Classification Committee for the Reclassification of Add to Reading List Source URL: www.medsafe.govt.nz Download Document from Source Website File Size: 101,69 KB Share Document on Facebook

	Restylane® Lyft with Lidocaine Injectable Gel with 0.3% Lidocaine Caution: Federal Law restricts this device to sale by or on the order of a physician or licensed practitioner. Description DocID: 1t1ZN - View Document
	PRESSEMITTEILUNG Merz erhält europäische Zulassung für Radiesse Lidocaine Merz Pharma GmbH & Co. KGaA DocID: 1sk9X - View Document
	Your partner for hands-on CNS electrophysiology DRG Na SET * DocID: 1rfCU - View Document
	Beilage 1: Arzneimittelmonographien DocID: 1qRET - View Document
	ismp-hosp-temp-MASTER.qxd DocID: 1qIK8 - View Document